CYTK - Cytokinetics, Incorporated

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5552.39M
Enterprise Value 3480.08M
Trailing P/E N/A
Forward P/E 1-5.50
PEG Ratio (5 yr expected) 1-0.38
Price/Sales (ttm)15.92
Price/Book (mrq)156.89
Enterprise Value/Revenue 313.84
Enterprise Value/EBITDA 6-5.55

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 0.00%
Operating Margin (ttm)-251.61%

Management Effectiveness

Return on Assets (ttm)-22.81%
Return on Equity (ttm)-204.67%

Income Statement

Revenue (ttm)34.7M
Revenue Per Share (ttm)0.63
Quarterly Revenue Growth (yoy)60.70%
Gross Profit (ttm)-57.63M
EBITDA -86.45M
Net Income Avi to Common (ttm)-105.37M
Diluted EPS (ttm)-1.93
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)176.62M
Total Cash Per Share (mrq)3.06
Total Debt (mrq)52.37M
Total Debt/Equity (mrq)1,552.94
Current Ratio (mrq)7.09
Book Value Per Share (mrq)0.06

Cash Flow Statement

Operating Cash Flow (ttm)-98.31M
Levered Free Cash Flow (ttm)-70.93M

Trading Information

Stock Price History

Beta (3Y Monthly) 2.09
52-Week Change 320.91%
S&P500 52-Week Change 34.71%
52 Week High 311.33
52 Week Low 35.75
50-Day Moving Average 39.18
200-Day Moving Average 37.76

Share Statistics

Avg Vol (3 month) 3629.57k
Avg Vol (10 day) 3473.55k
Shares Outstanding 557.72M
Float 49.04M
% Held by Insiders 17.32%
% Held by Institutions 175.19%
Shares Short (Apr 30, 2019) 43.99M
Short Ratio (Apr 30, 2019) 47.4
Short % of Float (Apr 30, 2019) 48.79%
Short % of Shares Outstanding (Apr 30, 2019) 47.21%
Shares Short (prior month Mar 29, 2019) 43.03M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 26/1
Last Split Date 3Jun 25, 2013